07.04.2023

Quality Assistance confirms its leadership in analytical sciences

With a €20Mio investment to double its operational surface and to ensure the continuous development of its teams, Belgian Contract Research Organization Quality Assistance gears up to maintain its European leadership in analytical sciences for biotech and pharmaceutical companies. The MITOSE expansion project, whose name refers to DNA replication, will create 6,000 m² of additional facilities making room for 100 new highly qualified jobs, resulting in a total capacity of 12,000 m² and 350 employees. The new building should be inaugurated by the end of 2024.

A historical organic growth model since 1982

Quality Assistance invests yet again in its unique site in Thuin (Belgium) thus confirming its strategy of organic growth and centralizing its offering of analytical services. Since 1982, Quality Assistance’s strategic positioning on innovative medicines and constant investment and thrive to increase both their operational capacity as well as their analytical added value have been key factors in the success of the company. In 2022, Quality Assistance achieved a turnover of 27 million euros, 77% coming from exports. It has recorded a Compound Annual Growth Rate of 9% over the last five years.

Continuing to develop its expertise and services dedicated to innovative medicines and emerging markets

By doubling the company’s operational capacity by the end of 2024, Quality Assistance aims to join the ranks of the major European research companies. The company expansion project MITOSE includes 6,000 m² of additional facilities to meet the growing demand of their clients and continue to develop services dedicated to more emerging markets such as Cell-Based Medicinal Products, mRNA and viral vectors. All in compliance with EMA and FDA requirements.

Quality Assistance plans to open a Pharma Academy for its team members

As the war for talent rages on, Quality Assistance takes the lead by investing in its Knowledge Management Program and creating its own Pharma Academy. Half of the new building will be dedicated to the training of its team members, the development of their business and interpersonal skills, as well as their well-being. In this way, the company maintains the level of excellence of its employees and the expertise delivered to best support its clients.

Sources: L'Echo, quality-assistance.com

Mithra CDMO Announces Collaboration with MedinCell for the Development of Injectable Products for Malaria and Transplant Rejection

Mithra announced a collaboration with MedinCell for the development of two long-acting injectable products in its CDMO based in Liège.

PDC*line Pharma new GMP manufacturing facility in Belgium

PDC*Line Pharma is setting-up its own GMP manufacturing facility in Liège, Belgium, to produce cancer vaccines for the next clinical trials.v

Making mRNA vaccine production in Africa a reality

Together with Afrigen Biologics, Quantoom Biosciences is paving the way for African mRNA vaccine production with its Ntensify™ Midi system.

Interested in updates on our insights, news and testimonials?